Issue navigation
Volume 15, Issue 11, November 2021
Editorials
Comforting Data on the Incidence of Rectal Cancer After Subtotal Colectomy in IBD: The Risk Is Low, Yet Surveillance Matters!
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1783–1784, https://doi.org/10.1093/ecco-jcc/jjab084
Cannabis and Inflammatory Bowel Disease: All Smoke and Mirrors?
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1785–1786, https://doi.org/10.1093/ecco-jcc/jjab091
Original Articles
Rectal Cancer Incidence is Low Following Rectal Diversion or Subtotal Colectomy for IBD: Results of a Population-based Study
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1787–1798, https://doi.org/10.1093/ecco-jcc/jjab090
Oral CBD-rich Cannabis Induces Clinical but Not Endoscopic Response in Patients with Crohn’s Disease, a Randomised Controlled Trial
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1799–1806, https://doi.org/10.1093/ecco-jcc/jjab069
Obesity in Inflammatory Bowel Disease Is Associated with Early Readmissions Characterised by an Increased Systems and Patient-level Burden
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1807–1815, https://doi.org/10.1093/ecco-jcc/jjab088
Prevalence and Impact of Obesity on Disease-specific Outcomes in a Population-based Cohort of Patients with Ulcerative Colitis
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1816–1823, https://doi.org/10.1093/ecco-jcc/jjab097
Association Between Inflammatory Bowel Disease and Psychiatric Morbidity and Suicide: A Swedish Nationwide Population-Based Cohort Study With Sibling Comparisons
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1824–1836, https://doi.org/10.1093/ecco-jcc/jjab039
Acceptance and Perceived Control are Independently Associated With Quality of Life in Inflammatory Bowel Disease: Introduction of a New Segmentation Model
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1837–1845, https://doi.org/10.1093/ecco-jcc/jjab082
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1846–1851, https://doi.org/10.1093/ecco-jcc/jjab070
Efficacy and Safety of Tofacitinib Re-treatment for Ulcerative Colitis After Treatment Interruption: Results from the OCTAVE Clinical Trials
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1852–1863, https://doi.org/10.1093/ecco-jcc/jjab065
Systematic Review: Sweet Syndrome Associated with Inflammatory Bowel Disease
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1864–1876, https://doi.org/10.1093/ecco-jcc/jjab079
The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1877–1884, https://doi.org/10.1093/ecco-jcc/jjab071
Histopathological Features in Colonic Biopsies at Diagnosis Predict Long-term Disease Course in Patients with Crohn’s Disease
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1885–1897, https://doi.org/10.1093/ecco-jcc/jjab087
Identification of Three Novel Susceptibility Loci for Inflammatory Bowel Disease in Koreans in an Extended Genome-Wide Association Study
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1898–1907, https://doi.org/10.1093/ecco-jcc/jjab060
Variants in STXBP3 are Associated with Very Early Onset Inflammatory Bowel Disease, Bilateral Sensorineural Hearing Loss and Immune Dysregulation
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1908–1919, https://doi.org/10.1093/ecco-jcc/jjab077
Ustekinuma b for Crohn’s Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1920–1930, https://doi.org/10.1093/ecco-jcc/jjab081
Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn’s Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 Study
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1931–1942, https://doi.org/10.1093/ecco-jcc/jjab089
Suppressing Kv1.3 Ion Channel Activity with a Novel Small Molecule Inhibitor Ameliorates Inflammation in a Humanised Mouse Model of Ulcerative Colitis
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1943–1958, https://doi.org/10.1093/ecco-jcc/jjab078
Review Article
Immunological Networks Defining the Heterogeneity of Inflammatory Bowel Diseases
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1959–1973, https://doi.org/10.1093/ecco-jcc/jjab085
